Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
02 Mayo 2023 - 4:01PM
Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that
Chairman and Chief Executive Officer Jim Green will present and
host one-on-one meetings with investors at the Sidoti Micro Cap
Virtual Conference taking place on May 10th, 2023.
Mr. Green will present on Wednesday, May 10th at 11:30 AM ET. A
live webcast of the presentation will be available here. The
presentation will also be archived on the Investor Relations
section of the Harvard Bioscience website for a limited period of
time.
Harvard Bioscience will also host virtual one-on-one meetings
with investors on Wednesday, May 10th, 2023
To register for the presentation or to schedule a one-on-one
meeting, please visit www.sidoti.com/events.
About Harvard Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer
and seller of technologies, products and services that enable
fundamental advances in life science applications, including
research, pharmaceutical and therapy discovery, bio-production and
preclinical testing for pharmaceutical and therapy development. Our
customers range from renowned academic institutions and government
laboratories to the world’s leading pharmaceutical, biotechnology
and contract research organizations. With operations in North
America, Europe, and China, we sell through a combination of direct
and distribution channels to customers around the world.
For more information, please visit our website
at www.harvardbioscience.com.
Investor Contact:
Harvard Bioscience, Inc. Investor Relations(508)
893-3120investors@harvardbioscience.com
Harvard Bioscience (NASDAQ:HBIO)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
Harvard Bioscience (NASDAQ:HBIO)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024